Literature DB >> 28095042

GAUGING THE EXTENT OF THYROIDECTOMY FOR INDETERMINATE THYROID NODULES: AN ONCOLOGIC PERSPECTIVE.

David F Schneider, Linda M Cherney Stafford, Nicole Brys, Caprice C Greenberg, Courtney J Balentine, Dawn M Elfenbein, Susan C Pitt.   

Abstract

OBJECTIVE: Increasing emphasis is being placed on appropriateness of care and avoidance of over- and under-treatment. Indeterminate thyroid nodules (ITNs) present a particular risk for this problem because cancer found via diagnostic lobectomy (DL) often requires a completion thyroidectomy (CT). However, initial total thyroidectomy (TT) for benign ITN results in lifelong thyroid hormone replacement. We sought to measure the accuracy and factors associated with the extent of initial thyroidectomy for ITN.
METHODS: We queried a single institution thyroid surgery database for all adult patients undergoing an initial operation for ITN. Multivariate logistic regression identified factors associated with either oncologic under- or overtreatment at initial operation.
RESULTS: There were 639 patients with ITN. The median age was 52 (range, 18 to 93) years, 78.4% were female, and final pathology revealed a cancer >1 cm in 24.7%. The most common cytology was follicular neoplasm (45.1%) followed by Hürthle cell neoplasm (20.2%). CT or initial oncologic undertreatment was required in 58 patients (9.3%). Excluding those with goiters, 19.0% were treated with TT for benign final pathology. Multivariate analysis failed to identify any factor that independently predicted the need for CT. Female gender was associated with TT in benign disease (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.0 to 4.5; P = .05). Age >45 years predicted correct initial use of DL (OR, 2.6; 95% CI, 1.2 to 5.7; P = .02). Suspicious for papillary thyroid carcinoma (OR, 5.7; 95% CI, 2.1 to 15.3; P<.01) and frozen section (OR, 9.7; 95% CI, 2.5 to 38.6; P<.01) were associated with oncologically appropriate initial TT. The highest frequency of CT occurred in patients with follicular lesion of undetermined significance (11.6%). TT for benign final pathology occurred most frequently in patients with a Hürthle cell neoplasm (24.8%).
CONCLUSION: In patients with ITN, nearly 30% received an inappropriate extent of initial thyroidectomy from an oncologic standpoint. Tools to pre-operatively identify both benign and malignant disease can assist in the complex decision making to gauge the proper extent of initial surgery for ITN. ABBREVIATIONS: ATA = American Thyroid Association AUS = atypia of undetermined significance CI = confidence interval CT = completion thyroidectomy FLUS = follicular lesion of undetermined significance ITN = indeterminate thyroid nodule OR = odds ratio PTC = papillary thyroid carcinoma TT = total thyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28095042      PMCID: PMC5403583          DOI: 10.4158/EP161540.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  40 in total

1.  Voice outcomes following reoperative central neck dissection for recurrent/persistent thyroid cancer.

Authors:  Heather Starmer; Salem I Noureldine; Ozan B Ozgursoy; Ralph P Tufano
Journal:  Laryngoscope       Date:  2015-07-07       Impact factor: 3.325

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Choosing wisely--the politics and economics of labeling low-value services.

Authors:  Nancy E Morden; Carrie H Colla; Thomas D Sequist; Meredith B Rosenthal
Journal:  N Engl J Med       Date:  2014-01-22       Impact factor: 91.245

4.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

Authors:  Erik K Alexander; Giulia C Kennedy; Zubair W Baloch; Edmund S Cibas; Darya Chudova; James Diggans; Lyssa Friedman; Richard T Kloos; Virginia A LiVolsi; Susan J Mandel; Stephen S Raab; Juan Rosai; David L Steward; P Sean Walsh; Jonathan I Wilde; Martha A Zeiger; Richard B Lanman; Bryan R Haugen
Journal:  N Engl J Med       Date:  2012-06-25       Impact factor: 91.245

5.  A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.

Authors:  Linwah Yip; Laura I Wharry; Michaele J Armstrong; Ari Silbermann; Kelly L McCoy; Michael T Stang; Nobuyuki P Ohori; Shane O LeBeau; Christopher Coyne; Marina N Nikiforova; Julie E Bauman; Jonas T Johnson; Mitch E Tublin; Steven P Hodak; Yuri E Nikiforov; Sally E Carty
Journal:  Ann Surg       Date:  2014-07       Impact factor: 12.969

6.  Appropriateness of referral of coronary angiography patients in Sweden. SECOR/SBU Project Group.

Authors:  S J Bernstein; B Brorsson; T Aberg; H Emanuelsson; R H Brook; L Werkö
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

Review 7.  Incidental thyroid nodules and thyroid cancer: considerations before determining management.

Authors:  Ralph P Tufano; Salem I Noureldine; Peter Angelos
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-06       Impact factor: 6.223

8.  Role of surgeon-performed ultrasound in predicting malignancy in patients with indeterminate thyroid nodules.

Authors:  William Méndez; Steven E Rodgers; John I Lew; Raquel Montano; Carmen C Solórzano
Journal:  Ann Surg Oncol       Date:  2008-07-12       Impact factor: 5.344

9.  Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.

Authors:  Sarah C Oltmann; David F Schneider; Glen Leverson; Tamilselvan Sivashanmugam; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2013-12-31       Impact factor: 5.344

10.  Local molecular analysis of indeterminate thyroid nodules.

Authors:  Mandeep S Gill; Smriti Nayan; Linda Kocovski; Jean-Claude Cutz; Stuart D Archibald; Bernard S Jackson; James E M Young; Michael K Gupta
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-12-01
View more
  7 in total

1.  Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes.

Authors:  Amanda K Price; Reese W Randle; David F Schneider; Rebecca S Sippel; Susan C Pitt
Journal:  J Surg Res       Date:  2017-06-21       Impact factor: 2.192

2.  Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.

Authors:  Courtney J Balentine; David J Vanness; David F Schneider
Journal:  Surgery       Date:  2017-11-08       Impact factor: 3.982

3.  Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.

Authors:  Whitney S Goldner; Trevor E Angell; Sallie Lou McAdoo; Joshua Babiarz; Peter M Sadow; Fadi A Nabhan; Christian Nasr; Richard T Kloos
Journal:  Thyroid       Date:  2019-09-27       Impact factor: 6.568

4.  Follicular proliferation TIR3B: the role of total thyroidectomy vs lobectomy.

Authors:  Andrea Polistena; Alessandro Sanguinetti; Roberta Lucchini; Stefano Avenia; Sergio Galasse; Raffaele Farabi; Massimo Monacelli; Nicola Avenia
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

5.  Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.

Authors:  Cristina Alina Silaghi; Vera Lozovanu; Carmen Emanuela Georgescu; Raluca Diana Georgescu; Sergiu Susman; Bogdana Adriana Năsui; Anca Dobrean; Horatiu Silaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-13       Impact factor: 5.555

6.  Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).

Authors:  Shilpa Thakur; Andrew Tobey; Brianna Daley; Sungyoung Auh; Mary Walter; Dhaval Patel; Naris Nilubol; Electron Kebebew; Aneeta Patel; Kirk Jensen; Vasyl Vasko; Joanna Klubo-Gwiezdzinska
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

7.  Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.

Authors:  Susan C Pitt; Megan C Saucke; Elizabeth M Wendt; David F Schneider; Jason Orne; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel
Journal:  Thyroid       Date:  2020-11-04       Impact factor: 6.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.